Consensus is $8.67. For fiscal 2024, the company now expects as reported revenue to increase 10-11%, an increase from previous expectations of 9-10%. Consensus is $5.44B. Expectations for constant currency organic revenue growth are also increased to 7-8% from prior expectations of 6-7%. The primary driver of the increase in revenue growth is the outperformance of the Healthcare segment.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on STE:
- Tesla downgraded, UPS upgraded: Wall Street’s top analyst calls
- Steris resumed with an Overweight at KeyBanc
- STE Upcoming Earnings Report: What to Expect?
- STERIS Announces Dividend of $0.52 per share
- STERIS to Host a Conference Call for Fiscal 2024 Third Quarter Financial Results on February 8, 2024
